Evidence map›Paper›PMID 41568622›Full record

ArticleMacromolecular rapid communications2026

Exploring Use of an Orthogonal Crosslinker to Create Controlled Thermoresponsive Hydrogels from LCST Tunable Thermoresponsive Polymers.

Hiroaki Kato, Kira B Landenberger

Abstract read
In one paragraph

Article in Macromolecular rapid communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hiroaki KatoDepartment of Polymer Chemistry, Kyoto University, Kyoto, Japan.
Kira B LandenbergerDepartment of Polymer Chemistry, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0003-1592-6466

Funding

Japan Chemical Fiber Research Institute, Public Interest Incorporated FoundationJapan Society for the Promotion of Science
6 · The paper itself

Abstract

Herein, a novel approach to create macroscale lower critical solution temperature (LCST) thermoresponsive hydrogels in a controlled manner using living cationic polymerization and a subsequent radical reaction is presented. By using a crosslinker capable of orthogonal reactions, 4-(vinyloxy)butyl methacrylate (VBM), which contains both vinyl ether and methacrylate moieties that react via cationic polymerization and radical reactions respectively, tremendous control over both the synthesis of the polymer structure as well as the hydrogel structure and its macroscale size and shape, by a post-polymerization UV light initiated radical reaction, is achieved. A series of random copolymers with the orthogonal crosslinker VBM, and LCST thermoresponsive monomers, methoxy ethyl vinyl ether (MOVE) or ethoxy ethyl vinyl ether (EOVE) or both, are synthesized. Introduction of VBM, even in small quantities, causes significant decreases in the observed phase transition temperatures for these thermoresponsive polymers and enables tuning of these temperatures. The hydrogels created from these polymers also exhibit clear LCST behavior with phase transition temperatures that are generally higher than for their corresponding polymers and over a wider temperature range. The use of this orthogonal reaction approach allows for control and design over both the polymer structure as well as that of the hydrogel.

Indexed as

Cross-Linking ReagentsHydrogelsPolymersTemperatureMethacrylatesMolecular StructurePhase TransitionPolymerizationVinyl CompoundsCross-Linking ReagentsHydrogelsMethacrylatesPolymersVinyl Compoundscationic polymerizationhydrogellower critical solution temperatureorthogonal crosslinking reactionphase transition temperatureradical reactionthermoresponsive

Identifiers

PMID41568622
PMCPMC13193361

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.